Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Nov 13, 2018
The pancreatic cancer drug of GlaxoSmithKline moves to phase 1 The experimental drug, GSK095 of GlaxoSmithKline is made to work in order with a checkpoint that are inhibiting medicines in the empowerment of the immune system to introduce a more aggressive attack against tumours than with checkpoint inhibitors alone...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper